Shinichiro Fuse

Shinichiro Fuse is a seasoned professional in the life sciences sector, currently serving as Partner/Managing Director at TPG since October 2021, where responsibilities include co-leading the Life Sciences Innovations Fund and holding board positions with Santa Ana Bio and Sudo Biosciences. Prior experience includes roles as Interim CEO and Board Member of Orna Therapeutics, as well as key advisory and leadership positions at ElevateBio, MPM Capital, and bluebird bio. Shinichiro Fuse's extensive background encompasses business development, venture capital, and corporate strategy, supported by a robust academic foundation with a Ph.D. in Microbiology and Immunology from the Geisel School of Medicine at Dartmouth, alongside master's and bachelor's degrees from The University of Tokyo and Keio University, respectively.